262 related articles for article (PubMed ID: 16186218)
21. Obligatory requirement for antibody in recovery from a primary poxvirus infection.
Chaudhri G; Panchanathan V; Bluethmann H; Karupiah G
J Virol; 2006 Jul; 80(13):6339-44. PubMed ID: 16775322
[TBL] [Abstract][Full Text] [Related]
22. Genetic resistance to smallpox: lessons from mousepox.
Karupiah G; Panchanathan V; Sakala IG; Chaudhri G
Novartis Found Symp; 2007; 281():129-36; discussion 136-40, 208-9. PubMed ID: 17534070
[TBL] [Abstract][Full Text] [Related]
23. Mousepox, a small animal model of smallpox.
Esteban D; Parker S; Schriewer J; Hartzler H; Buller RM
Methods Mol Biol; 2012; 890():177-98. PubMed ID: 22688768
[TBL] [Abstract][Full Text] [Related]
24. Evidence for Persistence of Ectromelia Virus in Inbred Mice, Recrudescence Following Immunosuppression and Transmission to Naïve Mice.
Sakala IG; Chaudhri G; Scalzo AA; Eldi P; Newsome TP; Buller RM; Karupiah G
PLoS Pathog; 2015 Dec; 11(12):e1005342. PubMed ID: 26700306
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Taterapox Virus in Small Animals.
Parker S; Crump R; Hartzler H; Buller RM
Viruses; 2017 Aug; 9(8):. PubMed ID: 28763036
[TBL] [Abstract][Full Text] [Related]
26. The mature virion of ectromelia virus, a pathogenic poxvirus, is capable of intrahepatic spread and can serve as a target for delayed therapy.
Ma X; Xu RH; Roscoe F; Whitbeck JC; Eisenberg RJ; Cohen GH; Sigal LJ
J Virol; 2013 Jun; 87(12):7046-53. PubMed ID: 23596297
[TBL] [Abstract][Full Text] [Related]
27. Comparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicity.
Hersperger AR; Siciliano NA; Eisenlohr LC
J Virol; 2012 Jul; 86(13):7298-309. PubMed ID: 22532670
[TBL] [Abstract][Full Text] [Related]
28. N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.
Gratz MS; Suezer Y; Kremer M; Volz A; Majzoub M; Hanschmann KM; Kalinke U; Schwantes A; Sutter G
J Virol; 2011 Apr; 85(7):3557-69. PubMed ID: 21270149
[TBL] [Abstract][Full Text] [Related]
29. Buccal viral DNA as a trigger for brincidofovir therapy in the mousepox model of smallpox.
Crump R; Korom M; Buller RM; Parker S
Antiviral Res; 2017 Mar; 139():112-116. PubMed ID: 28039021
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpox.
Parker S; Chen NG; Foster S; Hartzler H; Hembrador E; Hruby D; Jordan R; Lanier R; Painter G; Painter W; Sagartz JE; Schriewer J; Mark Buller R
Antiviral Res; 2012 Apr; 94(1):44-53. PubMed ID: 22381921
[TBL] [Abstract][Full Text] [Related]
31. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
[TBL] [Abstract][Full Text] [Related]
32. The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination.
Xu RH; Cohen M; Tang Y; Lazear E; Whitbeck JC; Eisenberg RJ; Cohen GH; Sigal LJ
J Exp Med; 2008 Apr; 205(4):981-92. PubMed ID: 18391063
[TBL] [Abstract][Full Text] [Related]
33. Development of a SYBR Green I real-time PCR for detection and quantitation of orthopoxvirus by using Ectromelia virus.
Cheng W; He X; Jia H; Chen G; Wang C; Zhang J; Jing Z
Mol Cell Probes; 2018 Apr; 38():45-50. PubMed ID: 29224776
[TBL] [Abstract][Full Text] [Related]
34. Ectromelia virus upregulates the expression of heat shock protein 70 to promote viral replication.
Cheng W; Jia H; Wang X; He X; Jin Q; Cao J; Jing Z
Int J Mol Med; 2018 Aug; 42(2):1044-1053. PubMed ID: 29749430
[TBL] [Abstract][Full Text] [Related]
35. A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease.
Israely T; Paran N; Lustig S; Erez N; Politi B; Shafferman A; Melamed S
Virol J; 2012 Jun; 9():119. PubMed ID: 22709563
[TBL] [Abstract][Full Text] [Related]
36. Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox.
Chaudhri G; Panchanathan V; Buller RM; van den Eertwegh AJ; Claassen E; Zhou J; de Chazal R; Laman JD; Karupiah G
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9057-62. PubMed ID: 15184649
[TBL] [Abstract][Full Text] [Related]
37. Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies.
Parker S; Siddiqui AM; Oberle C; Hembrador E; Lanier R; Painter G; Robertson A; Buller RM
Virology; 2009 Mar; 385(1):11-21. PubMed ID: 19100593
[TBL] [Abstract][Full Text] [Related]
38. The efficacy of cidofovir treatment of mice infected with ectromelia (mousepox) virus encoding interleukin-4.
Robbins SJ; Jackson RJ; Fenner F; Beaton S; Medveczky J; Ramshaw IA; Ramsay AJ
Antiviral Res; 2005 Apr; 66(1):1-7. PubMed ID: 15781125
[TBL] [Abstract][Full Text] [Related]
39. The Viral Protein Poly(A) Polymerase Catalytic Subunit Interacts with Guanylate-Binding Proteins 2 to Antagonize the Antiviral Ability of Targeting Ectromelia Virus.
Gao Z; He X; Chen G; Fang Y; Meng Z; Tian H; Zhang H; Jing Z
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958732
[TBL] [Abstract][Full Text] [Related]
40. Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics.
Parker S; Siddiqui AM; Painter G; Schriewer J; Buller RM
Viruses; 2010 Sep; 2(9):1918-1932. PubMed ID: 21994714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
